Thank you christian Torp-Pedersen and Kristian for helping this newbie with the code and to Dr. Deepak L. Bhatt Muthu Vaduganathan Tor Biering-Sørensen, MD, MSc, MPH, PhD Christina Byrne Jannik Pallisgaard Martin Bødtker Mortensen Michael Maeng Emil Fosbøl Gunnar Gislason Anders Nissen Bonde Thue Olsen and Lars, Christina, and Anna for perfecting the paper.

Procedural Outcomes After Percutaneous Coronary Interventions in Focal and Diffuse Coronary Artery Disease #AHAJournals jeroen sonck Michael Maeng Daniel Munhoz Marta Belmonte ahajrnls.org/3UHueY6

New JACC paper out on the risk associated with diabetes. Diabetes patients develop ASCVD 10-12 years earlier than people without diabetes, and the young ones are at greatest risk of premature ASCVD! Gyldenkerne, Maeng et al. JACC 2023;82:1583-1594 tctmd.com/news/diabetes-…

An important paper in our understanding of why autoimmune diseases increase the risk of ischemic heart disease! Association of Autoimmune Diseases With Coronary Atherosclerosis Severity and Ischemic Events pubmed.ncbi.nlm.nih.gov/38897674/

Excited to share our findings on 10-year mortality after STEMI, now in JACC Journals 👉STEMI patients surviving the first 90 days have only mildly elevated mortality compared to a matched general population. doi.org/10.1016/j.jacc… Michael Maeng #STEMI #cardiotwitter

Consistent Renal Benefits of Semaglutide in CKD and T2DM Patients With or Without SGLT2 Inhibitors Use. FLOW Trial Written by Cecilia Bahit Summary, analysis, and more #ADA2024 coverage below! cardiologynownews.org/consistent-ren… C. Michael Gibson MD